JP2013067589A - 口角炎または亀裂性湿疹の治療用医薬組成物 - Google Patents
口角炎または亀裂性湿疹の治療用医薬組成物 Download PDFInfo
- Publication number
- JP2013067589A JP2013067589A JP2011207778A JP2011207778A JP2013067589A JP 2013067589 A JP2013067589 A JP 2013067589A JP 2011207778 A JP2011207778 A JP 2011207778A JP 2011207778 A JP2011207778 A JP 2011207778A JP 2013067589 A JP2013067589 A JP 2013067589A
- Authority
- JP
- Japan
- Prior art keywords
- eczema
- pharmaceutical composition
- stomatitis
- antifungal agent
- fissure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 201000004624 Dermatitis Diseases 0.000 title claims abstract description 31
- 208000010668 atopic eczema Diseases 0.000 title claims abstract description 31
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 31
- 201000003465 angular cheilitis Diseases 0.000 title abstract 5
- 208000007287 cheilitis Diseases 0.000 title abstract 5
- 229940121375 antifungal agent Drugs 0.000 claims abstract description 32
- 239000003429 antifungal agent Substances 0.000 claims abstract description 31
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims abstract description 21
- VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical compound NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 claims abstract description 14
- GNVMUORYQLCPJZ-UHFFFAOYSA-M Thiocarbamate Chemical compound NC([S-])=O GNVMUORYQLCPJZ-UHFFFAOYSA-M 0.000 claims abstract description 9
- 239000004480 active ingredient Substances 0.000 claims abstract description 5
- 208000003265 stomatitis Diseases 0.000 claims description 27
- 239000003814 drug Substances 0.000 claims description 17
- OCAPBUJLXMYKEJ-UHFFFAOYSA-N 1-[biphenyl-4-yl(phenyl)methyl]imidazole Chemical compound C1=NC=CN1C(C=1C=CC(=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 OCAPBUJLXMYKEJ-UHFFFAOYSA-N 0.000 claims description 4
- 229960002206 bifonazole Drugs 0.000 claims description 4
- DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 claims description 4
- 229960000699 terbinafine hydrochloride Drugs 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 7
- 241000233866 Fungi Species 0.000 description 11
- 229940079593 drug Drugs 0.000 description 10
- 239000006071 cream Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 208000003322 Coinfection Diseases 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000005336 cracking Methods 0.000 description 2
- 238000006748 scratching Methods 0.000 description 2
- 230000002393 scratching effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 description 1
- AFNXATANNDIXLG-SFHVURJKSA-N 1-[(2r)-2-[(4-chlorophenyl)methylsulfanyl]-2-(2,4-dichlorophenyl)ethyl]imidazole Chemical compound C1=CC(Cl)=CC=C1CS[C@H](C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 AFNXATANNDIXLG-SFHVURJKSA-N 0.000 description 1
- LEZWWPYKPKIXLL-UHFFFAOYSA-N 1-{2-(4-chlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl}imidazole Chemical compound C1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 LEZWWPYKPKIXLL-UHFFFAOYSA-N 0.000 description 1
- 208000000412 Avitaminosis Diseases 0.000 description 1
- WHPAGCJNPTUGGD-UHFFFAOYSA-N Croconazole Chemical compound ClC1=CC=CC(COC=2C(=CC=CC=2)C(=C)N2C=NC=C2)=C1 WHPAGCJNPTUGGD-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- ZRTQSJFIDWNVJW-WYMLVPIESA-N Lanoconazole Chemical compound ClC1=CC=CC=C1C(CS\1)SC/1=C(\C#N)N1C=NC=C1 ZRTQSJFIDWNVJW-WYMLVPIESA-N 0.000 description 1
- BYBLEWFAAKGYCD-UHFFFAOYSA-N Miconazole Chemical compound ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 BYBLEWFAAKGYCD-UHFFFAOYSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000893966 Trichophyton verrucosum Species 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960004022 clotrimazole Drugs 0.000 description 1
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 description 1
- 229960002042 croconazole Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 229960003913 econazole Drugs 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- -1 isconazole Chemical compound 0.000 description 1
- 229960004125 ketoconazole Drugs 0.000 description 1
- 229950010163 lanoconazole Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000003120 macrolide antibiotic agent Substances 0.000 description 1
- 229960002509 miconazole Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- VWOIKFDZQQLJBJ-DTQAZKPQSA-N neticonazole Chemical compound CCCCCOC1=CC=CC=C1\C(=C/SC)N1C=NC=C1 VWOIKFDZQQLJBJ-DTQAZKPQSA-N 0.000 description 1
- 229950010757 neticonazole Drugs 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229960003483 oxiconazole Drugs 0.000 description 1
- QRJJEGAJXVEBNE-MOHJPFBDSA-N oxiconazole Chemical compound ClC1=CC(Cl)=CC=C1CO\N=C(C=1C(=CC(Cl)=CC=1)Cl)\CN1C=NC=C1 QRJJEGAJXVEBNE-MOHJPFBDSA-N 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 150000004291 polyenes Chemical class 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 229960002607 sulconazole Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
- 208000030401 vitamin deficiency disease Diseases 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
【解決手段】 本発明者は、上記課題を解決するために鋭意検討した結果、抗真菌剤が、口角炎および亀裂性湿疹に対して効果を発揮することを見出した。本発明に係る口角炎または亀裂性湿疹の治療用医薬組成物は、抗真菌剤を有効成分として含むことによって、口角炎または亀裂性湿疹の治療に好適に用いることができる。すなわち、本発明は、抗真菌剤を有効成分として含む、口角炎または亀裂性湿疹の治療用医薬組成物を提供する。また、本発明は、抗真菌剤がチオカルバメート系、イミダゾール系およびアリルアミン系からなる群より選択される少なくとも一つの抗真菌剤である、上記口角炎または亀裂性湿疹の治療用医薬組成物を提供する。
【選択図】なし
Description
口角炎を患っている患者(40代男性)の患部に対し、チオカルバメート系薬剤であるリラナフタートを含む医薬組成物(商品名:ゼフナートクリーム(鳥居薬品株式会社製))を塗布した。その結果、1回塗布したのみで、口角炎が治った。
口角炎を患っている10人の患者(0〜5歳)の各患部に対し、チオカルバメート系薬剤であるリラナフタートを含む医薬組成物(商品名:ゼフナートクリーム(鳥居薬品株式会社製))を塗布した。その結果、全ての患者において、口角炎が完治した。
手にあかぎれ(亀裂性湿疹)を患っている患者(37歳女性)の患部に対し、イミダゾール系薬剤であるビホナゾールを含む医薬組成物(商品名:マイコスポールクリーム(バイエル薬品株式会社製))を塗布した。塗布するタイミングは朝および入浴後の1日2回とし、2ヶ月続けた。その結果、亀裂性湿疹が完治した。
手にあかぎれ(亀裂性湿疹)を患っている患者(40歳女性)の患部に対し、アリルアミン系薬剤である塩酸テルビナフィンを含む医薬組成物(商品名:ラミシールクリーム(ノバルティスファーマ株式会社製))を塗布した。塗布するタイミングは1日1回とし、約4ヶ月続けた。その結果、亀裂性湿疹が完治した。
Claims (4)
- 抗真菌剤を有効成分として含む、口角炎または亀裂性湿疹の治療用医薬組成物。
- 前記抗真菌剤は、チオカルバメート系、イミダゾール系およびアリルアミン系からなる群より選択される少なくとも一つの抗真菌剤である、請求項1に記載の口角炎または亀裂性湿疹の治療用医薬組成物。
- 前記抗真菌剤は、リラナフタート、ビホナゾールおよび塩酸テルビナフィンである、請求項1または2に記載の口角炎または亀裂性湿疹の治療用医薬組成物。
- 外用薬である、請求項1〜3のいずれか1項に記載の口角炎または亀裂性湿疹の治療用医薬組成物。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011207778A JP5980488B2 (ja) | 2011-09-22 | 2011-09-22 | 口角炎の治療用医薬組成物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011207778A JP5980488B2 (ja) | 2011-09-22 | 2011-09-22 | 口角炎の治療用医薬組成物 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2013067589A true JP2013067589A (ja) | 2013-04-18 |
JP5980488B2 JP5980488B2 (ja) | 2016-08-31 |
Family
ID=48473726
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011207778A Expired - Fee Related JP5980488B2 (ja) | 2011-09-22 | 2011-09-22 | 口角炎の治療用医薬組成物 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5980488B2 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106266493A (zh) * | 2016-09-14 | 2017-01-04 | 四川聚豪生物科技有限公司 | 一种用于治疗剥脱性唇炎的中药组合物及制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001163783A (ja) * | 1999-09-28 | 2001-06-19 | Shoei:Kk | 皮膚疾患治療用外用剤 |
JP2003095943A (ja) * | 2001-09-21 | 2003-04-03 | Fujisawa Pharmaceut Co Ltd | 抗真菌組成物 |
JP2008069109A (ja) * | 2006-09-14 | 2008-03-27 | Ikeda Mohandou:Kk | 外用医薬組成物 |
-
2011
- 2011-09-22 JP JP2011207778A patent/JP5980488B2/ja not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001163783A (ja) * | 1999-09-28 | 2001-06-19 | Shoei:Kk | 皮膚疾患治療用外用剤 |
JP2003095943A (ja) * | 2001-09-21 | 2003-04-03 | Fujisawa Pharmaceut Co Ltd | 抗真菌組成物 |
JP2008069109A (ja) * | 2006-09-14 | 2008-03-27 | Ikeda Mohandou:Kk | 外用医薬組成物 |
Non-Patent Citations (2)
Title |
---|
"歯科医学大辞典", 歯科医学大事典 縮刷版, vol. 第1版, JPN6015029596, 10 October 1989 (1989-10-10), pages 793頁, ISSN: 0003121276 * |
治療薬マニュアル2007, JPN6016013331, 2007, pages 1652 - 1653, ISSN: 0003297967 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106266493A (zh) * | 2016-09-14 | 2017-01-04 | 四川聚豪生物科技有限公司 | 一种用于治疗剥脱性唇炎的中药组合物及制备方法 |
Also Published As
Publication number | Publication date |
---|---|
JP5980488B2 (ja) | 2016-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Roberts | Onychomycosis: current treatment and future challenges | |
Faergemann et al. | Pityrosporum ovale (Malassezia furfur) as the causative agent of seborrhoeic dermatitis: new treatment options | |
KR101184834B1 (ko) | 진균성 피부염용제 | |
US6281239B1 (en) | Method of treating onychomycosis | |
Sonthalia et al. | Topical ciclopirox olamine 1%: revisiting a unique antifungal | |
KR102433868B1 (ko) | 연성 항콜린성 유사체를 위한 제제 | |
KR20190037229A (ko) | 상승효과적 항진균 조성물 및 그의 방법 | |
Zaug et al. | Amorolfine in the treatment of onychomycoses and dermatomycoses (an overview) | |
DK165440B (da) | Farmaceutiske praeparater til topisk anvendelse indeholdende propylenglycol og/eller polyethylenglycol og urinstof som aktive hovedbestanddele | |
JP2011529038A5 (ja) | ||
JP2016166228A (ja) | Pde5抑制剤を含む皮膚しわ改善用組成物 | |
KR101333892B1 (ko) | 항진균 조성물 | |
RU2012149863A (ru) | Полисахарид семени тамаринда для применения в лечении микробных инфекций | |
EA022847B1 (ru) | Дезинфицирующий и антисептический препарат, имеющий сниженное содержание йода | |
KR20110074513A (ko) | 피부 감염의 국소 치료법 | |
US6673842B2 (en) | Method of treating onychomycosis | |
EP2508231A2 (en) | Imidazoles for treating multi-drug resistant bacterial infections | |
Köse et al. | Comparison of a single 400 mg dose versus a 7-day 200 mg daily dose of itraconazole in the treatment of tinea versicolor | |
Rai et al. | Tinea versicolor–an epidemiology | |
CN105188691A (zh) | 用于治疗组织创伤的α-肾上腺素能激动剂 | |
JP5980488B2 (ja) | 口角炎の治療用医薬組成物 | |
US6986896B2 (en) | Method of treating fungal conditions of the skin | |
Jacobs | Treatment of fungal skin infections: state of the art | |
US20170027881A1 (en) | Composition and related methods for treatment of pilosebaceous diseases | |
JP2018530622A (ja) | 尿路感染症を治療するための組成物および方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20140919 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20140919 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20140919 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150728 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150918 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20151021 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20151125 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20160412 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160610 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20160628 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20160727 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5980488 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |